Broadcasting News

Moon Geun-young, Who Just Got Married, Joins "Our Ballad 2"

'Our Ballad' Starring Top Actress Baek-gwi First recording scheduled for August

Gim Ga Yeong
2026-07-30 16:43:43
[Edaily Starin Gim Ga Yeong Reporter] Actress Moon Geun-young is joining the SBS audition project “Our Ballad 2.”
On the 30th, SBS announced that Moon Geun-young will join “Our Ballad 2.” As the first female “Top 100 Representative” on the show, Moon is expected to demonstrate her exceptional ability to empathize with the contestants’ unique stories and songs.
“Our Ballad” is a collective intelligence music survival audition show in which a 150-member “Top 100 Delegation”—comprising music experts as well as ordinary people of all ages—searches for new voices. Following the success of Season 1, Season 2 has been produced.
Season 2 will begin full-scale production starting with its first recording this August. According to SBS, the number of applicants for Season 2 has nearly tripled compared to last year, and the average age of participants has dropped to 17.9 years old.
“Our Ballad 2” will premiere on SBS this October.
Meanwhile, Moon Geun-young is making headlines after announcing her marriage to actor Jeong Pyeong on the 29th.

Economy

Corporation

IT·Science

Economy

From Buildings to Operating Companies… Rental Housing Platforms Swallowed Whole

The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
2026-08-11 00:34:03

Corporation

SK hynix Responds to Rumors of Chongqing Plant Stake Sale: "Nothing Has Been Finalized"

SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
2026-08-10 18:53:57

IT·Science

Medy-Tox Inc. Reports 11% Increase in Second-Quarter Revenue… ‘NewViju’ Emerges as New Growth Engine

Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …
2026-08-10 17:02:01